Cited by 17Advanced Glycation End Products researchClinical Laboratory Practices and Quality ControlDiabetes Management and Research

Use of Fructosyl Peptide Oxidase for HbA1c Assay

Open access
Yonehara, Satoshi, Inamura, Norio, Fukuda, Miho, Sugiyama, Koji·2015·Journal of Diabetes Science and Technology

Abstract

ARKRAY, Inc developed the world's first automatic glycohemoglobin analyzer based on HPLC (1981). After that, ARKRAY developed enzymatic HbA1c assay "CinQ HbA1c" with the spread and diversification of HbA1c measurement (2007). CinQ HbA1c is the kit of Clinical Chemistry Analyzer, which uses fructosyl peptide oxidase (FPOX) for a measurement reaction. This report mainly indicates the developmental background, measurement principle, and future of the enzymatic method HbA1c reagent.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/1932296815569573

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Enzymatic methods are widely used in centralized laboratories and rely on endoglycosidase digestion followed by quantification of released glycated amino acids.

    “In addition, although enzymatic methods are widely used in centralized laboratories and rely on endoglycosidase digestion followed by quantification of released glycated amino acids, no studies of enzymatic POC platforms met our inclusion criteria (42-44).”

    From Comparison of point‑of‑care HbA1c devices with laboratory HPLC methods: A systematic review and meta‑analysis (2026) · cites this paper as [42]

    The Abstract (page unavailable) describes an enzymatic HbA1c assay on an automatic analyzer: protease releases the glycated peptide fructosyl-Val-His, which is measured through an FPOX reaction. The Conclusion (page unavailable) says the method enables high-volume measurement on a clinical chemistry analyzer. These passages support an automated laboratory assay involving digestion and measurement of a glycated product, but they do not establish that enzymatic methods are widely used, and they specify protease and a glycated peptide—not endoglycosidase and released glycated amino acids. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [1]1. Akai T, Naka K, Okuda K, et al. A full-automated analyzer for HbA1c using newly developed stationary phase. Proc Symp Chem Physiol Pathol. 1982;21:110-113. [Google Scholar]
  2. [2]2. Shirata T, Noguchi N, Nakajima E, et al. Evaluation of enzymatic measurement kit for HbA1c “CinQ HbA1c.” Japanese Journal of Medical Technology 2009;58:189-194. [Google Scholar]
  3. [3]3. Sasaki M, Nishi H, Mizugami M, et al. Fundamental study of enzyme-based reagent, “glycohemoglobin A1c kit CinQ HbA1c” for measurement of HbA1c. Japanese J Clin Lab Automation. 2009;34:77-80. [Google Scholar]

Cited by

Sorted by citations

Authors
Yonehara, S., Inamura, N., Fukuda, M., & Sugiyama, K.
Affiliations
Arkray (Japan) (JP)
Corresponding author
Yonehara, Satoshi
Venue
Journal of Diabetes Science and Technology
Published
2015-01-28
Volume
9
Issue
2
Pages
200-205
ISSN
1932-2968 (ISSN-L)
OpenAlex
W2135198587
Cited by
16
References
10
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 2 · 2021: 1 · 2020: 1 · 2019: 4 · 2017: 2 · 2016: 2
FWCI
1.10
Type
journal article
Language
en
Open access
Locations
  • Journal of Diabetes Science and Technology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Health Sciences › Medicine › Physiology › Clinical Laboratory Practices and Quality Control
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
glycohemoglobin, clinical chemistry analyzers, diabetes monitoring
MeSH terms
Amino Acid Oxidoreductases, Blood Chemical Analysis, Diabetes Mellitus, Glycated Hemoglobin, Humans, Reagent Kits, Diagnostic, History, 20th Century, Enzyme Assays

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review